Found 96 matching trials
Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer PHASE2 This is a prospective, multicenter, single-arm, open-label study. The main ...
Show More Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Learn More & Join Trial
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer PHASE2 Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Show More Location
Baylor College of Medicine
Learn More & Join Trial
CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer PHASE1 This phase I trial studies the side effects and best dose of CPI-613 when g...
Show More Location
Comprehensive Cancer Center of Wake Forest University
Learn More & Join Trial
Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer. PHASE3 PANThEON is a randomized, open-label, multicenter phase III trial aimed at ...
Show More Location
Centro Di Riferimento Oncologico Di Aviano
Learn More & Join Trial
Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma PHASE2 Surgical resection is the only potentially curative treatment for patients ...
Show More Location
Smilow Cancer Hospital
Learn More & Join Trial
A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer PHASE2 In this Phase II study a dose of 2.8 mg (eight 0.35 mg siG12D-LODERs) will ...
Show More Location
Hackensack Meridian Health
Learn More & Join Trial
Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies PHASE1 Phase 1 Safety and Tolerability Study in Subjects with Pancreatic Cancer or...
Show More Location
HonorHealth Research Institute
Learn More & Join Trial
AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer PHASE3 This is a prospective, single-center, randomized, controlled phase Ⅲ study....
Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Learn More & Join Trial
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer PHASE1 This is an open label, multi-center, multi-arm, dose-escalation study of BB...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Modified FOLFIRINOX (mFFX) or Gemcitabine Plus Nab-paclitaxel (GnP) Therapy as First-line Treatment in Patients With Metastatic Pancreatic Cancer PHASE1 This study is a multicenter, open-label, uncontrolled study to investigate ...
Show More Location
National Cancer Center Hospital East
Learn More & Join Trial